Vectors Research Management’s Eastman Chemical EMN Stock Holding History

Vectors Research Management’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-91	Closed	-$8K	–	242
2022 Q2	$8K	Buy	91 +56	+160%	+$5.8K	﹤0.01%	391
2022 Q1	$4K	Hold	35	–	–	﹤0.01%	414
2021 Q4	$4K	Hold	35	–	–	﹤0.01%	523
2021 Q3	$4K	Hold	35	–	–	﹤0.01%	428
2021 Q2	$4K	Hold	35	–	–	﹤0.01%	453
2021 Q1	$4K	Hold	35	–	–	﹤0.01%	399
2020 Q4	$4K	Sell	35 -14	-29%	-$1.3K	﹤0.01%	385
2020 Q3	$4K	Hold	49	–	–	﹤0.01%	349
2020 Q2	$3K	Hold	49	–	–	﹤0.01%	373
2020 Q1	$2K	Sell	49 -802	-94%	-$51.5K	﹤0.01%	425
2019 Q4	$67K	Hold	851	–	–	0.03%	165
2019 Q3	$63K	Hold	851	–	–	0.03%	154
2019 Q2	$66K	Hold	851	–	–	0.04%	147
2019 Q1	$65K	Hold	851	–	–	0.04%	151
2018 Q4	$62K	Buy	851 +149	+21%	+$11.9K	0.03%	174
2018 Q3	$70K	Buy	+702	New	+$69.6K	0.04%	157

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vectors Research Management's EMN Position: Q3 2022 in Review

Vectors Research Management sold out of Eastman Chemical (EMN) in Q3 2022, closing a stake of 91 shares — an estimated $8K sold.

Vectors Research Management first reported a position in EMN in Q3 2018 and held it in 16 quarters. The position peaked at $70K in Q3 2018. 656 funds tracked by Wall St. Rank hold EMN as of Q3 2022.

Vectors Research Management reported no remaining Eastman Chemical position as of Q3 2022 after selling out during the quarter.
Vectors Research Management sold 91 Eastman Chemical shares in Q3 2022, an estimated $8K.
Vectors Research Management first reported a position in Eastman Chemical in Q3 2018 and held it in 16 quarters.
Vectors Research Management's Eastman Chemical position peaked at $70K in Q3 2018.
656 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2022.

Based on Vectors Research Management's 13F filing for Q3 2022, filed 8 Nov 2022.